Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
371M
-
Number of holders
-
297
-
Total 13F shares, excl. options
-
204M
-
Shares change
-
+5.91M
-
Total reported value, excl. options
-
$4.45B
-
Value change
-
+$108M
-
Put/Call ratio
-
2.45
-
Number of buys
-
126
-
Number of sells
-
-139
-
Price
-
$21.85
Significant Holders of Bausch Health Companies Inc. - Common Stock, no par value (BHC) as of Q3 2019
402 filings reported holding BHC - Bausch Health Companies Inc. - Common Stock, no par value as of Q3 2019.
Bausch Health Companies Inc. - Common Stock, no par value (BHC) has 297 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 204M shares
of 371M outstanding shares and own 55.01% of the company stock.
Largest 10 shareholders include FIL Ltd (27.7M shares), PAULSON & CO. INC. (20.8M shares), ValueAct Holdings, L.P. (17.9M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (13.8M shares), VANGUARD GROUP INC (9.68M shares), GOLDENTREE ASSET MANAGEMENT LP (6.8M shares), Connor, Clark & Lunn Investment Management Ltd. (5.89M shares), BANK OF MONTREAL /CAN/ (5.81M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (5.23M shares), and RENAISSANCE TECHNOLOGIES LLC (5.06M shares).
This table shows the top 297 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.